BHC
Bausch Health Companies IncNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$2.04B
P/E Ratio
—
EPS
$-3.24
Beta
0.42
52W High
$8.69
52W Low
$4.41
50-Day MA
$5.44
200-Day MA
$6.30
Dividend Yield
—
Profit Margin
-11.50%
Forward P/E
1.25
PEG Ratio
0.01
About Bausch Health Companies Inc
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.
Fundamentals
| Revenue (TTM) | $10.53B |
| Gross Profit (TTM) | $7.48B |
| EBITDA | $3.61B |
| Operating Margin | 20.60% |
| Return on Equity | 43.60% |
| Return on Assets | 5.93% |
| Revenue/Share (TTM) | $28.33 |
| Book Value | $-5.51 |
| Price-to-Book | 18.78 |
| Price-to-Sales (TTM) | 0.19 |
| EV/Revenue | 2.046 |
| EV/EBITDA | 11.14 |
| Quarterly Earnings Growth (YoY) | 1368.00% |
| Quarterly Revenue Growth (YoY) | 11.70% |
| Shares Outstanding | $373.48M |
| Float | $260.41M |
| % Insiders | 10.78% |
| % Institutions | 65.11% |
Historical Volatility
HV 10-Day
45.34%
HV 20-Day
36.10%
HV 30-Day
33.30%
HV 60-Day
38.91%
HV Rank
2.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($7.50 target)
1
Strong Buy8
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026